Dual Inhibition of Platelet-activating Factor and Arachidonic Acid Metabolism by Ajmaline and Effect on Carrageenan-induced Rat Paw Oedema
- 1 August 1993
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 45 (8), 715-719
- https://doi.org/10.1111/j.2042-7158.1993.tb07095.x
Abstract
The effects of ajmaline on human platelet aggregation, arachidonate metabolism and platelet activating factor (PAF)-induced lethality in rabbits were examined. Platelet aggregation induced by several stimuli (ADP, collagen, and PAF) was inhibited by increasing concentrations of ajmaline. The potency of ajmaline was higher when PAF was employed as stimulating agent in comparison with other agonists (IC50 70, 270 and 380 μm for PAF, ADP and collagen, respectively) whereas ajmaline had no effect against arachidonic acid-induced aggregation. In contrast however, ajmaline inhibited arachidonate metabolism by platelet homogenates. The formation of both thromboxane A2 and 12-hydroxy-eicosatetraenoic acid was inhibited by ajmaline with comparable potencies. Pretreatment of rabbits with ajmaline (50 mg kg−1) completely abolished the lethal effects of PAF (11 μg kg−1) given intravenously (P < 0·001). In addition, ajmaline at doses ranging from 50 to 100 mg kg−1 inhibited carrageenan-induced rat paw oedema (P < 0·001). In this test ajmaline was three times more potent than aspirin. In the light of these results we conclude that ajmaline, a known anti-arrhythmic agent is a PAF antagonist and a dual inhibitor of platelet cyclo-oxygenase and lipoxygenase enzymes with anti-inflammatory properties.Keywords
This publication has 16 references indexed in Scilit:
- Selective inhibition of platelet-activating factor by antiarrhythmic drugs in human plateletsBiochemical Society Transactions, 1989
- Role of Thromboxane A2 as a Mediator of Platelet-Activating-Factor-Induced Aggregation of Human PlateletsClinical Science, 1989
- Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusionEuropean Journal of Pharmacology, 1989
- Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in ratsBritish Journal of Pharmacology, 1988
- Intravenous injections of PAF-acether induce platelet aggregation in ratsEuropean Journal of Pharmacology, 1988
- Paf-acether: a mediator of inflammation and asthmaTrends in Pharmacological Sciences, 1984
- Isolation of a new lipoxygenase metabolite of arachidonic acid, 8,11,12-trihydroxy-5,9,14-eicosatrienoic acid from human plateletsProstaglandins, 1979
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- THE PLATELET AS AN INFLAMMATORY CELL*Annals of the New York Academy of Sciences, 1972
- Clinical pharmacologic observations of the effects of ajmaline in chronic atrial fibrillationClinical Pharmacology & Therapeutics, 1963